Edwards Lifesciences (EW) Cash & Equivalents (2009 - 2026)
Edwards Lifesciences (EW) reported Cash & Equivalents of $3.11 billion for Q3 2026, up 15.8% from $2.69 billion a year earlier and up 7.0% from the prior quarter.
Powered by 
Analysis
Edwards Lifesciences (EW) Cash & Equivalents (2009 - 2026) Analysis & Trends
At the end of FY2025, Edwards Lifesciences posted Cash & Equivalents of $2.94 billion, down 3.5% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of 19.9% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $3.05 billion in FY2024 (+168.9%), $1.13 billion in FY2023 (+47.2%), $769 million in FY2022 (-10.9%) and $862.8 million in FY2021 (-27.1%).
- The Q3 2026 figure ranks as the highest quarterly Cash & Equivalents since Q2 2025.
- Year over year, Cash & Equivalents gained in four of the last eight quarters, with growth averaging 47.1%.
- The high point for year-over-year Cash & Equivalents in five years was Q4 2024 (growth of 168.9%); the low point was Q4 2021 (a decline of 27.1%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $2.91 billion (Q2 2026), $2.45 billion (Q1 2026) and $2.94 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 266.22 Bn | 242.86 Bn | 5.13 Bn | 5.46 Bn |
| 2 | Abbott Laboratories | 191.31 Bn | 165.77 Bn | 7.39 Bn | 4.05 Bn |
| 3 | Danaher | 166.16 Bn | 145.82 Bn | 3.84 Bn | 5.68 Bn |
| 4 | Intuitive Surgical | 155.98 Bn | 136.40 Bn | 2.08 Bn | 2.98 Bn |
| 5 | Medtronic | 130.05 Bn | 96.18 Bn | 6.34 Bn | 1.69 Bn |
| 6 | Stryker | 123.40 Bn | 109.59 Bn | 4.25 Bn | 3.27 Bn |
| 7 | Boston Scientific | 64.81 Bn | 60.48 Bn | 3.43 Bn | 609.00 Mn |
| 8 | Edwards Lifesciences | 59.87 Bn | 43.18 Bn | 1.35 Bn | 3.11 Bn |
| 9 | Medline | 53.84 Bn | 50.96 Bn | 1.93 Bn | 2.32 Bn |
| 10 | Agilent Technologies | 50.15 Bn | 43.04 Bn | 1.04 Bn | 1.76 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.11 Bn |
| Jun 30, 2026 | 2.91 Bn |
| Mar 31, 2026 | 2.45 Bn |
| Dec 31, 2025 | 2.94 Bn |
| Sep 30, 2025 | 2.69 Bn |
| Jun 30, 2025 | 3.27 Bn |
| Mar 31, 2025 | 3.14 Bn |
| Dec 31, 2024 | 3.05 Bn |
| Sep 30, 2024 | 3.68 Bn |
| Jun 30, 2024 | 1.64 Bn |
| Mar 31, 2024 | 1.22 Bn |
| Dec 31, 2023 | 1.13 Bn |
| Sep 30, 2023 | 1.41 Bn |
| Jun 30, 2023 | 1.04 Bn |
| Mar 31, 2023 | 872.50 Mn |
| Dec 31, 2022 | 769.00 Mn |
| Sep 30, 2022 | 1.25 Bn |
| Jun 30, 2022 | 1.20 Bn |
| Mar 31, 2022 | 1.03 Bn |
| Dec 31, 2021 | 862.80 Mn |
API Access
Edwards Lifesciences Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=EW&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "EW", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=EW&period=max&api_key=YOUR_API_KEY");
const data = await res.json();